| Document Date: 2014-06-09 11:19:20
Open Document File Size: 223,45 KBShare Result on Facebook
City Quebec Metropolitain / Moncton / Mississauga / Winnipeg / Montreal / Toronto / Calgary / / Company Eli Lilly / 7Amgen Canada Inc. / Johnson & Johnson / AEs / Amgen Inc. / Valeant Pharmaceuticals / Sanofi Aventis / Novartis / Valeo / Lilly / Cipher Pharmaceuticals / Celgene / LEO Pharma / Incyte / Actelion / Merck / Schering-Plough / Wyeth / Pfizer Canada Inc. / Amgen Canada Inc. / Immunex / / Country Canada / / / Event M&A / / IndustryTerm owned subsidiary / investigational product / / MedicalCondition Headache / Patients With Moderate-to-Severe Plaque Psoriasis / psoriasis / Psoriatic arthritis / tumor necrosis / moderate-to-severe plaque psoriasis / / Organization Speaker’s Bureau / Canadian Dermatology Association / 5Lynde Centre for Dermatology / / Person Papp / W. Lynde / Bissonnette / Toole / Honoraria / Barber / / Position Investigator / *Last Observation Carried Forward / static physician global assessment / Consultant / Investigator / Speaker / / Product calcitriol / betamethasone dipropionate / hydrocortisone / betamethasone valerate / / ProvinceOrState Alberta / Quebec / New Brunswick / Manitoba / Ontario / /
SocialTag |
The COMET Trial: Clinical Results in Moderate to Severe RA